2007 Fiscal Year Final Research Report Summary
Deve lopment of assay systems for detection anti-mouse antibody
| Project/Area Number |
18590534
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
TSUJI Naoki Sapporo Medical University, SCHOOL OF MEDICINE, ASSISTANT PROFESSOR (00347171)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
WATANABE Naoki SAPPORO MEDICAL UNIVERSITY, SCHOOL OF MEDICINE, Professor (10158644)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Keywords | ANTI-ANIMAL ANTIBODY / HAMA / ELISA FOR DETECTIONOF HAMA / HETEROPHILIC BLOCKING REAGENT |
|---|
| Research Abstract |
In the present study, we developed enzyme-linked immunosorvent assay (ELISA) for the detection of human anti-mouse antibodies (HAMA) in the serum and investigate the frequency of people possesses HAMA in Japan.
34 cases out of 290 cases (11.7%) were positive (IgG type ; 18 cases, IgM type 20 cases). The most frequent IgG subtype that HAMA recognized was IgG1 (IgG type ; 14 cases, IgM type 11 cases). In addition, some cases showed positive against two or three kinds of IgG subtype (IgG type ; IgG2a+IgG2b:3 rases, IgG1+IgG2a+IgG2b:1ca.p, IgM type ; IgG2a+IgG2b:5 cases, IgG1+IgG2a + IgG2b:2 case).
To eliminate the effect of HAMA on the immunoassays, heterophilic blocking reagent (HBR) which contains mouse immunoglobulins is added to sample or assay reagents. We then determined the effect of HBR on HAMA using ETISA system. When 10 or 15μl of HBR was added to 100 ul of sample, measured values were decreased to 30-50% of untreated samples. In contrast, when of HBR was added to sample, measured values were significantly increased 2-3 times of untreated samples. These results indicate that establishing the amount of HBR added to samples is important to block the effect of HAMA on the immunoassays.
|
-
-
-
-
-
-
-
[Journal Article] Specific overexpression of OLFM4GW112/hGC-1 mRNA in colon, breast, and lung cancer tissues detected using quantitative analysis2007
Author(s)
Koshida, S., Kobayashi, D., Moriai, R., Tsuji, N., Watanabe, N
-
Journal Title
Cancer Sci 98
Pages: 315-320
Description
「研究成果報告書概要(欧文)」より
-
-
[Journal Article] 15-Deoxy-Delta(12,14)-prostaglandin J(2) inhibits G(2)-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivn expression2007
Author(s)
Kamagata, C., Tsuji, N., Moriai, M., Kobayashi, D., Watanabe, N
-
Journal Title
Breast Cancer Res Treat 102
Pages: 263-273
Description
「研究成果報告書概要(欧文)」より
-
-
[Journal Article] Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer2007
Author(s)
Kaneko, R., Tsuji, N., Asanuma, K., Tanabe, H., Kobayashi, D., Watanabe, N
-
Journal Title
J Biol Chem 282
Pages: 19273-19281
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] In hibition of estrogen receptor β -mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Δ12, 14-prostaglandin J2-induced apoptosis in cancer cells2007
Author(s)
Kondo, K., Tsuji, N., Asanuma, K., Kobayashi, D., Watanabe, N
-
Journal Title
Exp Cell Res 313
Pages: 3486-3496
Description
「研究成果報告書概要(欧文)」より
-
-
-
-
-
-
